clorazepate dipotassium
Generic: clorazepate dipotassium
Labeler: apotex corp.Drug Facts
Product Profile
Brand Name
clorazepate dipotassium
Generic Name
clorazepate dipotassium
Labeler
apotex corp.
Dosage Form
TABLET
Routes
Active Ingredients
clorazepate dipotassium 3.75 mg/mg
Manufacturer
Identifiers & Regulatory
Product NDC
60505-4754
Product ID
60505-4754_ab0eda3d-5823-2483-7ecc-aa22d0a9e25f
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA215566
DEA Schedule
civ
Listing Expiration
2026-12-31
Marketing Start
2022-09-22
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
605054754
Hyphenated Format
60505-4754
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
clorazepate dipotassium (source: ndc)
Generic Name
clorazepate dipotassium (source: ndc)
Application Number
ANDA215566 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 3.75 mg/mg
Packaging
- 100 mg in 1 BOTTLE (60505-4754-1)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "ab0eda3d-5823-2483-7ecc-aa22d0a9e25f", "openfda": {"upc": ["0360505475650", "0360505475612"], "unii": ["63FN7G03XY"], "rxcui": ["197464", "197465", "197466"], "spl_set_id": ["6e07efe5-29b6-6d1e-661a-f696c4b17f43"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 mg in 1 BOTTLE (60505-4754-1)", "package_ndc": "60505-4754-1", "marketing_start_date": "20220922"}], "brand_name": "Clorazepate Dipotassium", "product_id": "60505-4754_ab0eda3d-5823-2483-7ecc-aa22d0a9e25f", "dosage_form": "TABLET", "pharm_class": ["Benzodiazepine [EPC]", "Benzodiazepines [CS]"], "product_ndc": "60505-4754", "dea_schedule": "CIV", "generic_name": "Clorazepate Dipotassium", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Clorazepate Dipotassium", "active_ingredients": [{"name": "CLORAZEPATE DIPOTASSIUM", "strength": "3.75 mg/mg"}], "application_number": "ANDA215566", "marketing_category": "ANDA", "marketing_start_date": "20220922", "listing_expiration_date": "20261231"}